Location: Home
  • search
  • go
  • Relate News
  • 8/21/2025Henlius Biotech Expands Oncology Portfolio with Strategic Licensing Ag...
  • 8/21/2025Bio-Thera Solutions Taps STADA to Bring BAT1806 to Global Markets
  • 8/21/2025NMPA Lifts Import Suspension on Vasudha's Loratadine API
  • 8/21/2025China Intensifies Biotech Support Amid Surge in Global Licensing Deals
  • 8/20/2025China Drives Asia-Pacific Health Care Transformation Amid Rising Costs...
  • 8/19/2025CANbridge Announces Strategic Partnership and Investment from Baheal 
  • 8/19/2025BioNTech's BNT327 Shows Strong Phase II Results as China-Originated Dr...
  • 8/19/2025RemeGen and Santen Enter into Licensing Deal for Ophthalmic Drug RC28-...
  • 8/19/2025Innovent Presents Phase 2 Study of Tarlatamab in Third-Line ES-SCLC at...
  • 8/19/2025China Unveils Nine Key Healthcare Insurance Priorities for 2025
  • 8/19/2025CSPC Pharma Advances in Biosimilars with Dupilumab Injection Approval
  • 8/19/2025Eisai Launches First Orexin Receptor Antagonist for Insomnia in China
  • 8/19/2025U.S. Tariffs Pressure Mounting, Japanese Pharma Looks East for Growth ...
  • 8/19/2025Leaving China Manufacturing: The Hidden Risks And How To Protect Your ...
  • 8/18/2025Tarlatamab Shows Promising Results in Chinese Phase 2 Trial for Heavil...
  • 8/18/2025Pleryon Completes First Closing of Series A Financing
  • 8/15/2025NHSA Issues Interim Measures for Disease-Based Medical Insurance Payme...
  • 8/14/2025Amphastar Strikes Major Licensing Deal to Supercharge Peptide Pipeline
  • 8/14/2025YolTech Unveils Breakthru In Vivo Editing of Human Blood Stem Cells
  • 8/14/2025Remegen's Telitacicept Achieves Phase III Success
  • 8/14/2025CDE Solicits Comments on Draft ICH M4Q(R2) Guidelines for Drug Qualit...
  • 8/13/2025Merck Halts NSCLC Development of MK-1308 Amid Partnership with China's...
  • 8/13/2025NHSA Publishes Preliminary Review Results for 2025 NRDL Adjustments wi...
  • 8/13/2025Summit Skips Quarterly Earnings Call amid Strategic Shifts and BLA Pla...
  • 8/13/2025MNCs Target China's New Commercial Insurance Catalog to Gain Ground
  • 8/12/2025Akeso Doses First Patient in Phase III Trial of Ivonescimab
  • 8/11/2025Novo Nordisk Reports Solid Growth in China Amid Global Expansion in H1...
  • 8/8/2025Minghui's MHB042C Earns Green Light for Clinical Trials in Advanced So...
  • 8/8/2025AstraZeneca Expands Use of Fasenra in China
  • 8/8/2025Minghui Raises $131M to Accelerate Clinical and Commercial Expansion
  • Page:3/367 Total number of articles:10998: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group